Trupanion (NASDAQ:TRUP – Get Free Report) and NeueHealth (NYSE:NEUE – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation.
Valuation & Earnings
This table compares Trupanion and NeueHealth’s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Trupanion | $1.11 billion | 0.84 | -$44.69 million | ($1.08) | -20.53 |
| NeueHealth | $1.16 billion | 0.04 | -$1.15 billion | ($151.20) | -0.04 |
Trupanion has higher earnings, but lower revenue than NeueHealth. Trupanion is trading at a lower price-to-earnings ratio than NeueHealth, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Insider & Institutional Ownership
63.9% of NeueHealth shares are owned by institutional investors. 5.8% of Trupanion shares are owned by insiders. Comparatively, 64.3% of NeueHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Trupanion and NeueHealth’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Trupanion | -4.03% | -15.19% | -5.95% |
| NeueHealth | -71.23% | N/A | -1.21% |
Analyst Recommendations
This is a summary of current recommendations and price targets for Trupanion and NeueHealth, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Trupanion | 0 | 3 | 1 | 0 | 2.25 |
| NeueHealth | 0 | 1 | 0 | 0 | 2.00 |
Trupanion currently has a consensus price target of $33.20, indicating a potential upside of 49.75%. NeueHealth has a consensus price target of $8.00, indicating a potential upside of 35.36%. Given Trupanion’s stronger consensus rating and higher possible upside, research analysts clearly believe Trupanion is more favorable than NeueHealth.
Summary
Trupanion beats NeueHealth on 8 of the 14 factors compared between the two stocks.
About Trupanion
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
About NeueHealth
NeueHealth, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
